ScholarIQanswers from OpenAlex
Indiana University School of Medicine
InstitutionResearch output, impact & collaborations
Indiana University School of Medicine is a institution indexed in ScholarIQ from OpenAlex.
What is known about Indiana University School of Medicine?
ScholarIQrecord summary
Indiana University School of Medicine is a research organisation in Indianapolis. OpenAlex records 83,911 works and 7,312,372 citations for it. 16,904 researchers list it as their most recent affiliation.
How many works does Indiana University School of Medicine have?
ScholarIQindexed works
Indiana University School of Medicine has 83,911 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Indiana University School of Medicine have?
ScholarIQcitation count
Indiana University School of Medicine has 7,312,372 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Indiana University School of Medicine?
ScholarIQresearcher count
Indiana University School of Medicine has 16,904 researchers in the ScholarIQ index.
What is the average h-index at Indiana University School of Medicine?
ScholarIQavg h-index
Indiana University School of Medicine has an average h-index of 74.7 in OpenAlex.
What is the ROR of Indiana University School of Medicine?
ScholarIQror
The ROR for Indiana University School of Medicine is on the source record.
What is the OpenAlex record for Indiana University School of Medicine?
ScholarIQopenalex
The OpenAlex for Indiana University School of Medicine is on the source record.
Who are the most-cited researchers behind Indiana University School of Medicine?
ScholarIQtop researchers by citations
What are the most-cited papers on Indiana University School of Medicine?
ScholarIQmost cited works
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Ravindra L. Mehta, John A. Kellum, Sudhir V. Shah, Bruce A. Molitoris, Claudio Ronco, David G. Warnock, Adeera Levin, the Acute Kidney Injury Network
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman, Chengjie Xiong, Tammie L.S. Benzinger, Anne M. Fagan, Alison Goate, Nick C. Fox, Daniel S. Marcus, Nigel J. Cairns, Xianyun Xie, Tyler Blazey, David M. Holtzman, Anna Santacruz, Virginia Buckles, Angela Oliver, Krista L. Moulder, Paul Aisen, Bernardino Ghetti, William E. Klunk, Eric McDade, Ralph N. Martins, Colin L. Masters, Richard Mayeux, John M. Ringman, Martin N. Rossor, Peter R. Schofield, Reisa A. Sperling, Stephen Salloway, John C. Morris
Reducing Mortality from Colorectal Cancer by Screening for Fecal Occult Blood
Jack S. Mandel, John H. Bond, Timothy R. Church, Dale C. Snover, G. Mary Bradley, Leonard M. Schuman, Fred Ederer
Donanemab in Early Symptomatic Alzheimer Disease
John R. Sims, Jennifer A. Zimmer, Cynthia Evans, Ming‐Chi Lu, Paul Ardayfio, JonDavid Sparks, Alette M. Wessels, Sergey Shcherbinin, Hong Wang, Emel Serap Monkul Nery, Emily C. Collins, Paul R. Solomon, Stephen Salloway, Liana G. Apostolova, Oskar Hansson, Craig Ritchie, Dawn A. Brooks, Mark A. Mintun, Daniel Skovronsky, TRAILBLAZER-ALZ 2 Investigators, Rafael Abreu, Pinky Agarwal, Puja Aggarwal, Marc Agronin, Alison Allen, Dario Altamirano, Gustavo Alva, James Andersen, Allan Anderson, Donald D. Anderson, Jennifer Arnold, Takashi Asada, Yasuhiro Aso, Vikram Atit, Ricardo Ayala, Michael Badruddoja, Hanna Badzio-jagiello, Michal Bajaček, Dávid Barton, David G. Bear, Sabrina Benjamin, Richard Bergeron, Perminder Bhatia, Sandra E. Black, Allan Block, Mohammad Reza Bolouri, Wendy Bond, Jean Bouthillier, Sharon A. Brangman, Bruce J. Brew, Sarah Brisbin, Toby Brisken, Amy Brodtmann, Mark Brody, Jared R. Brosch, Celia Brown, Paul Brownstone, Sylwia Bukowczan, Jeffrey M. Burns, A Cabrera, Horace Capote, Ángel Carrasco, José Yépez, Eric Chavez, Howard Chertkow, Urszula Chyrchel-Paszkiewicz, Anthony Ciabarra, Edward Clemmons, Daniel M. Cohen, Robert M. Cohen, Ian J. Cohen, Mauricio Concha, Brian Costell, Denis Crimmins, Yvette Cruz-pagan, Adolfo Cueli, Robert Cupelo, Maciej Czarnecki, David Darby, P. L. J. Dautzenberg, Peter Paul De Deyn, Jose De La Gandara, Kenneth Deck, David DiBenedetto, Mark DiBuono, Eric Dinnerstein, Ahmet Dirican, Shanker Dixit, Jacek Dobryniewski, Ryan Drake, Peter Drysdale, Ranjan Duara, John P. Duffy, Aaron Ellenbogen, Victor Faradji, Marc Feinberg, Robert Feldman, Simon Fishman, Stephen Flitman, Concetta Forchetti
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
Nasser H. Hanna, Frances A. Shepherd, Frank V. Fossella, Jose R. Pereira, Filippo de Marinis, Joachim von Pawel, U. Gatzemeier, Thomas Chang Yao Tsao, Miklos Pless, Thomas Müller, Hong-Liang Lim, Christopher E. Desch, Klára Szondy, Radj Gervais, Shaharyar, Christian Manegold, Sofia Paul, Paolo Paoletti, Lawrence Einhorn, Paul A. Bunn
How much of the research on Indiana University School of Medicine is open access?
ScholarIQopen access share
83%OPEN ACCESS